64 tracked 13F filers disclose a position in IVA as of the latest SEC 13F filings, a combined $276.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Samsara BioCapital, LLC | $28.8M | 5.2M | —Held | Q1 2026 | |
| 2 | Caligan Partners LP | $27.6M | 5.0M | ▲+149% Added · +3.0M sh | Q1 2026 | |
| 3 | Paradigm Biocapital Advisors LP | $22.2M | 4.0M | —Held | Q1 2026 | |
| 4 | Andera Partners | $13.7M | 3.6M | ▲+100% Added · +1.8M sh | Q2 2026 | |
| 5 | MILLENNIUM MANAGEMENT LLC | $16.6M | 3.0M | ▲+13% Added · +335K sh | Q1 2026 | |
| 6 | Nantahala Capital Management, LLC | $10.2M | 2.7M | ▲New +2.7M sh | Q2 2026 | |
| 7 | Trails Edge Capital Partners, LP | $10.0M | 2.7M | —Held | Q2 2026 | |
| 8 | FRANKLIN TEMPLETON INC | $13.7M | 2.5M | ▼−1.5% Reduced · −39K sh | Q1 2026 | |
| 9 | UBS Group AG | $12.9M | 2.3M | ▼−12% Reduced · −325K sh | Q1 2026 | |
| 10 | ADAR1 Capital Management, LLC | $12.1M | 2.2M | ▼−20% Reduced · −535K sh | Q1 2026 | |
| 11 | Patient Square Capital LP | $7.4M | 2.0M | ▲New +2.0M sh | Q2 2026 | |
| 12 | CITADEL ADVISORS LLC | $6.7M | 1.8M | ▲27× Added · +1.7M sh | Q2 2026 | |
| 13 | Point72 Asset Management, L.P. | $6.4M | 1.7M | ▲+76% Added · +727K sh | Q2 2026 | |
| 14 | Integral Health Asset Management, LLC | $5.7M | 1.5M | ▲+280% Added · +1.1M sh | Q2 2026 | |
| 15 | Yu Fan | $5.7M | 1.5M | —Held | Q2 2026 | |
| 16 | BOOTHBAY FUND MANAGEMENT, LLC | $8.2M | 1.5M | ▲+123% Added · +811K sh | Q1 2026 | |
| 17 | NEA Management Company, LLC | $8.0M | 1.5M | —Held | Q1 2026 | |
| 18 | Ikarian Capital, LLC | $7.8M | 1.4M | ▲+184% Added · +927K sh | Q1 2026 | |
| 19 | Deep Track Capital, LP | $6.8M | 1.2M | ▲+149% Added · +732K sh | Q1 2026 | |
| 20 | Polar Capital Holdings Plc | $4.1M | 1.1M | ▼−50% Reduced · −1.1M sh | Q2 2026 | |
| 21 | AMERIPRISE FINANCIAL INC | $4.7M | 844K | ▲+37% Added · +229K sh | Q1 2026 | |
| 22 | HighVista Strategies LLC | $3.1M | 831K | ▲+35% Added · +216K sh | Q2 2026 | |
| 23 | Ally Bridge Group (NY) LLC | $4.1M | 745K | ▼−50% Reduced · −755K sh | Q1 2026 | |
| 24 | BVF INC/IL | $3.8M | 686K | —Held | Q1 2026 | |
| 25 | MARSHALL WACE, LLP | $3.6M | 654K | ▲+280% Added · +482K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 12 funds opened a new position in IVA and 21 added to an existing one, while 5 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 31 funds | $6.9B |
| CYTOKINETICS INCCYTK | 30 funds | $881.5M |
| ABIVAX SA-ADRABVX | 29 funds | $842.9M |
| NVIDIA CORPNVDA | 28 funds | $37.8B |
| AMAZON.COM INCAMZN | 28 funds | $23.3B |
| APPLIED MATERIALS INCAMAT | 28 funds | $3.8B |
| REVOLUTION MEDICINES INCRVMD | 28 funds | $2.1B |
| MICROSOFT CORPMSFT | 27 funds | $22.7B |
| MICRON TECHNOLOGY INCMU | 27 funds | $6.4B |
| SEAGATE TECHNOLOGY HOLDINGSSTX | 27 funds | $3.6B |
| BOSTON SCIENTIFIC CORPBSX | 27 funds | $2.8B |
| ORACLE CORPORCL | 27 funds | $2.8B |
Ranked by how many of IVA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 8, 2010 | VISCONTI JOSEPH C | CEO, President, Chairman, Director, 10% Owner | Buy (S) | 8K | $960 |
| Jul 8, 2010 | VISCONTI JOSEPH C | CEO, President, Chairman, Director, 10% Owner | Buy (S) | 10K | $2K |
| Jul 8, 2010 | VISCONTI JOSEPH C | CEO, President, Chairman, Director, 10% Owner | Buy (S) | 6K | $960 |
| Jul 8, 2010 | VISCONTI JOSEPH C | CEO, President, Chairman, Director, 10% Owner | Buy (S) | 6K | $960 |
| Jul 8, 2010 | VISCONTI JOSEPH C | CEO, President, Chairman, Director, 10% Owner | Buy (S) | 10K | $2K |
| Jul 8, 2010 | VISCONTI JOSEPH C | CEO, President, Chairman, Director, 10% Owner | Buy (S) | 8K | $960 |
| Dec 1, 2008 | VISCONTI JOSEPH C | President & CEO, Director, 10% Owner | Buy (P) | 500 | $75 |
| Dec 1, 2008 | VISCONTI JOSEPH C | President & CEO, Director, 10% Owner | Buy (P) | 45K | $7K |
| Nov 13, 2008 | VISCONTI JOSEPH C | President & CEO, Director, 10% Owner | Buy (P) | 20K | $4K |
| Nov 12, 2008 | VISCONTI JOSEPH C | President & CEO, Director, 10% Owner | Buy (P) | 17K | $3K |
| Nov 10, 2008 | VISCONTI JOSEPH C | President & CEO, Director, 10% Owner | Buy (P) | 2K | $396 |
| Nov 7, 2008 | VISCONTI JOSEPH C | President & CEO, Director, 10% Owner | Buy (P) | 17K | $3K |
Connected entities for IVA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/IVA/capital-change-brief"
Use Arkolith's capital_change_brief for IVA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for IVA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.